A Prospective Biomarker Study in Active SPMS Subjects Treated With Cladribine Tablets
Status:
Recruiting
Trial end date:
2025-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore the concept that biomarker sensitivity will detect
activity in Multiple Sclerosis (MS) subjects and allow appropriate change in treatment to
prevent dysfunction.